Evaluation of the effectiveness of transcranial direct current stimulation (tDCS) in patients with substance abuse

Phase 3

Recruiting

• Conditions: Condition 1: substance use disorder. Condition 2: Other stimulant dependence.; Opioid dependence; Other stimulant dependence; F11.2; F15.2

• Registration Number: IRCT20230430058029N1
• Lead Sponsor: Rasht University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 June 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

patients with opioid or methamphetamine substance use disorders (based on DSM-5 criteria).

Exclusion Criteria

Taking anticonvulsiant drugs in the last 6 months
Having neurological diseases
Pregnancy
Mental retardation
Presence of a complication in the skull
Presence of any metal in the skull or brain

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The amount of craving. Timepoint: 6 months.During the follow-up period, patients will be evaluated for substance use in three stages of 1 month, 3 months and 6 months. Method of measurement: Addiction Craving Scale (ACS) questionnaire.

Secondary Outcome Measures

Name	Time	Method
Quality of life. Timepoint: Before the intervention and in the follow-up period of 1 month, 3 months and 6 months. Method of measurement: SF-36 questionnaire score.;Data of EEG. Timepoint: Before the intervention and in the follow-up period of 1 month, 3 months and 6 months. Method of measurement: Brain signal processing.